Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix

IF van Luijk; C Coens; MEL Burg; A Kobierska; M Namer; C Lhomme; P Zola; G Zanetta; JB Vermorken

doi:10.1093/annonc/mdl384

Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix

IF van Luijk, C Coens, MEL Burg, A Kobierska, M Namer, C Lhomme, P Zola, G Zanetta, JB Vermorken

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	275-281
Number of pages	7
Journal	Annals of Oncology
Volume	18
Issue number	2
DOIs	https://doi.org/10.1093/annonc/mdl384
Publication status	Published - 2007

Research programs

EMC MM-03-86-08

Access to Document

10.1093/annonc/mdl384

http://hdl.handle.net/1765/36521

Cite this

@article{c17b5b5696114d73a97815b3ee99c40f,

title = "Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix",

author = "\{van Luijk\}, IF and C Coens and MEL Burg and A Kobierska and M Namer and C Lhomme and P Zola and G Zanetta and JB Vermorken",

year = "2007",

doi = "10.1093/annonc/mdl384",

language = "Undefined/Unknown",

volume = "18",

pages = "275--281",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "2",

}

TY - JOUR

T1 - Phase II study of bleomycin, vindesine, mitomycin C and cisplatin (BEMP) in recurrent or disseminated squamous cell carcinoma of the uterine cervix

AU - van Luijk, IF

AU - Coens, C

AU - Burg, MEL

AU - Kobierska, A

AU - Namer, M

AU - Lhomme, C

AU - Zola, P

AU - Zanetta, G

AU - Vermorken, JB

PY - 2007

Y1 - 2007

U2 - 10.1093/annonc/mdl384

DO - 10.1093/annonc/mdl384

M3 - Article

C2 - 17060485

SN - 0923-7534

VL - 18

SP - 275

EP - 281

JO - Annals of Oncology

JF - Annals of Oncology

IS - 2

ER -